Literature DB >> 19018291

From here to eternity - the secret of Pharaohs: Therapeutic potential of black cumin seeds and beyond.

Subhash Padhye1, Sanjeev Banerjee, Aamir Ahmad, Ramzi Mohammad, Fazlul H Sarkar.   

Abstract

Over many centuries humans have been mining the bounties of nature for discovering substances that have been used for the treatment of all human diseases; many such remedies are useful even today as modern day medicine. Emerging evidence also suggests that the search is still continuing for harnessing active compounds from nature in combating human illnesses although pharmaceutical industries are equally active for synthesizing small molecule compounds as novel therapeutics. The lesson learned over many centuries clearly suggests that further sophisticated search for finding compounds from natural resources together with robust characterization and chemical synthesis will lead to the discovery of novel drugs that may have high therapeutic efficacy against all human diseases including cancer. Black cumin seed (Nigella sativa) oil extracts have been used for many centuries for the treatment of many human illnesses, and more recently the active compound found in black seed oil, viz. thymoquinone (TQ) has been tested for its efficacy against several diseases including cancer. However, further research is needed in order to assess the full potential of TQ as a chemopreventive and/or therapeutic agent against cancers. Here, we have summarized what is known regarding the value of black seed oil and its active compound TQ, and how this knowledge will help us to advance further research in this field by creating awareness among scientists and health professionals in order to appreciate the medicinal value of TQ and beyond.

Entities:  

Year:  2008        PMID: 19018291      PMCID: PMC2583426     

Source DB:  PubMed          Journal:  Cancer Ther


  89 in total

1.  Allergic contact dermatitis from black cumin (Nigella sativa) oil-containing ointment.

Authors:  Sven Zedlitz; Roland Kaufmann; Wolf-Henning Boehncke
Journal:  Contact Dermatitis       Date:  2002-03       Impact factor: 6.600

2.  Crystal structure determination of thymoquinone by high-resolution X-ray powder diffraction.

Authors:  S Pagola; A Benavente; A Raschi; E Romano; M A A Molina; P W Stephens
Journal:  AAPS PharmSciTech       Date:  2004-02-19       Impact factor: 3.246

3.  Effects of thymoquinone, lycopene, and selenomethione in the presence of estrogen on the viability of SiHa cells in vitro.

Authors:  Joyce Brewer; Hamed Benghuzzi; Michelle Tucci
Journal:  Biomed Sci Instrum       Date:  2006

4.  Inhibition of benzo(a)pyrene-induced forestomach carcinogenesis in mice by thymoquinone.

Authors:  O A Badary; O A Al-Shabanah; M N Nagi; A C Al-Rikabi; M M Elmazar
Journal:  Eur J Cancer Prev       Date:  1999-10       Impact factor: 2.497

5.  Thymoquinone supplementation prevents the development of gentamicin-induced acute renal toxicity in rats.

Authors:  Mohamed M Sayed-Ahmed; Mahmoud N Nagi
Journal:  Clin Exp Pharmacol Physiol       Date:  2007 May-Jun       Impact factor: 2.557

6.  The influence of thymoquinone on doxorubicin-induced hyperlipidemic nephropathy in rats.

Authors:  O A Badary; A B Abdel-Naim; M H Abdel-Wahab; F M Hamada
Journal:  Toxicology       Date:  2000-03-07       Impact factor: 4.221

7.  LNCaP cells exposed to ceramic drug delivery treatment with epigallocatechin-3-gallate, thymoquinone, and tannic acid.

Authors:  Latoya Ross Richards; Pamala Jones; James Hughes; Hamed Benghuzzi; Michelle Tucci
Journal:  Biomed Sci Instrum       Date:  2007

8.  Nigella sativa and derived thymoquinone prevents hippocampal neurodegeneration after chronic toluene exposure in rats.

Authors:  Mehmet Kanter
Journal:  Neurochem Res       Date:  2007-10-11       Impact factor: 3.996

9.  Androgen receptor and E2F-1 targeted thymoquinone therapy for hormone-refractory prostate cancer.

Authors:  Ahmed O Kaseb; Kannagi Chinnakannu; Di Chen; Arun Sivanandam; Sheela Tejwani; Mani Menon; Q Ping Dou; G Prem-Veer Reddy
Journal:  Cancer Res       Date:  2007-08-15       Impact factor: 12.701

10.  The in vitro anti-tumor activity of some crude and purified components of blackseed, Nigella sativa L.

Authors:  D R Worthen; O A Ghosheh; P A Crooks
Journal:  Anticancer Res       Date:  1998 May-Jun       Impact factor: 2.480

View more
  58 in total

Review 1.  Review on molecular and therapeutic potential of thymoquinone in cancer.

Authors:  Sanjeev Banerjee; Subhash Padhye; Asfar Azmi; Zhiwei Wang; Philip A Philip; Omer Kucuk; Fazlul H Sarkar; Ramzi M Mohammad
Journal:  Nutr Cancer       Date:  2010       Impact factor: 2.900

2.  Structure-activity studies on therapeutic potential of Thymoquinone analogs in pancreatic cancer.

Authors:  Sanjeev Banerjee; Asfar S Azmi; Subhash Padhye; Marjit W Singh; Jubaraj B Baruah; Philip A Philip; Fazlul H Sarkar; Ramzi M Mohammad
Journal:  Pharm Res       Date:  2010-04-27       Impact factor: 4.200

3.  Effects of thymoquinone in the expression of mucin 4 in pancreatic cancer cells: implications for the development of novel cancer therapies.

Authors:  Maria P Torres; Moorthy P Ponnusamy; Subhankar Chakraborty; Lynette M Smith; Srustidhar Das; Hwyda A Arafat; Surinder K Batra
Journal:  Mol Cancer Ther       Date:  2010-04-27       Impact factor: 6.261

4.  Blockade of nitric oxide overproduction and oxidative stress by Nigella sativa oil attenuates morphine-induced tolerance and dependence in mice.

Authors:  Ahmed O Abdel-Zaher; Mahran S Abdel-Rahman; Fahmy M ELwasei
Journal:  Neurochem Res       Date:  2010-06-15       Impact factor: 3.996

5.  Anti-inflammatory effects of thymoquinone in activated BV-2 microglial cells.

Authors:  Equar Taka; Elizabeth A Mazzio; Carl B Goodman; Natalie Redmon; Hernan Flores-Rozas; Renee Reams; Selina Darling-Reed; Karam F A Soliman
Journal:  J Neuroimmunol       Date:  2015-06-27       Impact factor: 3.478

Review 6.  Down-regulation of UHRF1, associated with re-expression of tumor suppressor genes, is a common feature of natural compounds exhibiting anti-cancer properties.

Authors:  Mahmoud Alhosin; Tanveer Sharif; Marc Mousli; Nelly Etienne-Selloum; Guy Fuhrmann; Valérie B Schini-Kerth; Christian Bronner
Journal:  J Exp Clin Cancer Res       Date:  2011-04-15

7.  The Antioxidant Effects of Thymoquinone in Activated BV-2 Murine Microglial Cells.

Authors:  Makini K Cobourne-Duval; Equar Taka; Patricia Mendonca; David Bauer; Karam F A Soliman
Journal:  Neurochem Res       Date:  2016-09-01       Impact factor: 3.996

8.  Thymoquinone increases the expression of neuroprotective proteins while decreasing the expression of pro-inflammatory cytokines and the gene expression NFκB pathway signaling targets in LPS/IFNγ -activated BV-2 microglia cells.

Authors:  Makini K Cobourne-Duval; Equar Taka; Patricia Mendonca; Karam F A Soliman
Journal:  J Neuroimmunol       Date:  2018-05-04       Impact factor: 3.478

9.  Thymoquinone induces telomere shortening, DNA damage and apoptosis in human glioblastoma cells.

Authors:  Resham Lal Gurung; Shi Ni Lim; Aik Kia Khaw; Jasmine Fen Fen Soon; Kirthan Shenoy; Safiyya Mohamed Ali; Manikandan Jayapal; Swaminathan Sethu; Rajamanickam Baskar; M Prakash Hande
Journal:  PLoS One       Date:  2010-08-12       Impact factor: 3.240

Review 10.  New targets for the treatment of follicular lymphoma.

Authors:  Nishant Tageja; Subhash Padheye; Prasad Dandawate; Ayad Al-Katib; Ramzi M Mohammad
Journal:  J Hematol Oncol       Date:  2009-12-23       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.